remdesivir
More News
-
India's Cipla says supply of Covid-19 drug remdesivir catching up with demand
Backorders, complaints over low supply started moderating in the second week of May, says drugmaker
-
Single patient study adds to debate over Gilead's remdesivir for Covid-19
A World Health Organisation-led trial found in October that it failed to improve Covid-19 survival rates
-
WHO advises against remdesivir drug for all Covid-19 patients
Manufacturer Gilead questions Solidarity Trial’s results, says it was disappointed at the new WHO guideline
-
FDA approves emergency use of arthritis drug in combination with remdesivir to treat Covid-19
Olumiant is an oral medication used to treat moderately-to-severely active rheumatoid arthritis
-
US Food and Drug Administration approves antiviral remdesivir to treat Covid-19
Remdesivir is the first and only drug approved in United States for treating patients with Covid-19
-
WHO halts hydroxychloroquine, HIV drugs in covid trials after failure to reduce death
A WHO-led trial is looking at the potential effect of Gilead’s antiviral drug remdesivir on Covid-19
-
Govt allows duty-free import of Remdesivir
Allows tax-free import of 60 other tools used in treatment of Covid-19 until Sept 30
-
What you need to know about the coronavirus right now
Many scientists believe antibody based therapies hold great promise for treating infected people
-
Gilead trades that made millions on Covid-19 drug news raise eyebrows
Gilead’s shares jumped nearly 10% following a media report detailing encouraging partial data from trials
-
Pakistan to import remdesivir from Bangladesh
Searle Company Limited has entered into an exclusive licensing, marketing agreement with Beximco Pharmaceuticals
